Speaker illustration

Doctor Nikita Kochergin

Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo (Russian Federation)

Member of:

Randomized clinical trial of surgical vs. percutaneous vs. hybrid revasculatization in multivessel coronary artery disease: 3 years follow-up (the HREVS Trial)

Event: ESC Congress 2020

Topic: Coronary Arteries

Session: Cardiovascular Surgery Potpourri


1-year follow-up of hybrid coronary revascularization for multi-vessel coronary artery disease amongst patients with stable coronary artery disease.

Event: ESC Congress 2017

Topic: Angina pectoris stable

Session: Stable CAD


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb